Cosmo Bio Co (3386.T) Akcie Kurz

Cosmo Bio Co., Ltd. engages in export, import, and sale of bio-research reagents, instruments and software, and clinical diagnostics. The company is headquartered in Koto-Ku, Tokyo-To and currently employs 146 full-time employees. The company went IPO on 2005-09-27. Research reagents business imports majority research reagents from United States and Europe, which are prioritized in life science related research. In the equipment business, the Company handles equipment specialized in life science research, purchases goods from a wide range of domestic and overseas, and mainly sells it to the domestic market. The equipment includes ultrasonic cell disruption equipment, bioimaging related equipment and research consumables. The firm provides clinical test drugs mainly used at hospitals and testing centers.